A previous study found it expressed in either tumor or stroma are associated with a positive response to immunotherapy in a metastatic melanoma patient cohort.[18] We also found that ABL2 and APLP2 are the most significantly upregulated genes in the non‐responding cell group (see Figure 3c). The gene discussed is ABL2; the disease is metastatic melanoma.